Patent details
EP2475427 Title: ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
Basic Information
- Publication number:
- EP2475427
- PCT Application Number:
- PCT/US/2010/048322
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP108161092
- PCT Publication Number:
- WO/2011/031901
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
- French Title of Invention:
- ANTAGONISTES D'ACTRIIB, ET DOSAGE ET ADMINISTRATION ASSOCIÉS
- German Title of Invention:
- ACTRIIB-ANTAGONISTEN, IHRE DOSIERUNG UND ANWENDUNGEN DAVON
- SPC Number:
Dates
- Filing date:
- 09/09/2010
- Grant date:
- 30/11/2016
- EP Publication Date:
- 30/11/2016
- PCT Publication Date:
- 17/03/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/07/2012
- EP B1 Publication Date:
- 30/11/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/09/2017
- Expiration date:
- 09/09/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/09/2010
- Name:
- Acceleron Pharma Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
Inventor
1
- Name:
- ATTIE Ken
- Address:
- United States (US)
2
- Name:
- SEEHRA Jasbir
- Address:
- United States (US)
3
- Name:
- KNOPF John
- Address:
- United States (US)
Priority
- Priority Number:
- 276287 P
- Priority Date:
- 09/09/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61P 19/08;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|